nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Data Monitoring Committees: Current issues
|
Fleming, Thomas R |
|
2018 |
15 |
4 |
p. 321-328 |
artikel |
2 |
Data sharing platforms for de-identified data from human clinical trials
|
Huser, Vojtech |
|
2018 |
15 |
4 |
p. 413-423 |
artikel |
3 |
How to construct an optimal interim report: What the data monitoring committee does and doesn’t need to know
|
Neaton, James D |
|
2018 |
15 |
4 |
p. 359-365 |
artikel |
4 |
Incidence and impact of withdrawal of life-sustaining therapies in clinical trials of severe traumatic brain injury: A systematic review
|
Leblanc, Guillaume |
|
2018 |
15 |
4 |
p. 398-412 |
artikel |
5 |
Modeling adverse event counts in phase I clinical trials of a cytotoxic agent
|
Muenz, Daniel G |
|
2018 |
15 |
4 |
p. 386-397 |
artikel |
6 |
Proceedings of the University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding Data and Safety Monitoring Committees in clinical trials
|
Ellenberg, Susan S |
|
2018 |
15 |
4 |
p. 319-320 |
artikel |
7 |
The independent statistician model: How well is it working?
|
DeMets, David |
|
2018 |
15 |
4 |
p. 329-334 |
artikel |
8 |
University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (afternoon panel session)
|
Dickersin, Kay |
|
2018 |
15 |
4 |
p. 366-385 |
artikel |
9 |
University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (morning panel session)
|
Davis, Barry |
|
2018 |
15 |
4 |
p. 335-351 |
artikel |
10 |
Use of composite outcomes to assess risk–benefit in clinical trials
|
Shaw, Pamela A |
|
2018 |
15 |
4 |
p. 352-358 |
artikel |